title: The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.
abstract: EMT6 multicellular spheroids were introduced into the peritoneal cavities of mice and allowed to become vascularised, resulting in solid spherical tumours. The necrotic cores of the initially avascular spheroids were replaced by vascularised tumour tissue but the outer zones of the spheroids failed to become vascularised. The presence of both vascular and avascular components in each spheroid allowed the role of the vasculature in the antitumour action of flavone acetic acid (FAA) to be determined. Eighteen hours after treatment with FAA 0.8 mmol kg-1, the vascularised core became necrotic and haemorrhagic, while the outer avascular zone remained viable. Tumour cells which were infiltrating superficial sub-mesothelial fat did not become necrotic despite the presence of numerous thrombi in associated vessels. Injection of two fluorescent vascular markers, the first (Hoechst 33342) together with FAA, and the second (10-nonyl acridine orange) 4 h later, demonstrated that there is a marked loss of blood flow in the spheroids. These results provide further evidence that FAA kills blood vessel-dependent tumour cells by interrupting the tumour blood supply.
authors.affiliation: Department of Pathology, University of Auckland School of Medicine, New Zealand.
authors.forename: L J
authors.initials: LJ
authors.lastname: Zwi
authors.forename: B C
authors.initials: BC
authors.lastname: Baguley
authors.forename: J B
authors.initials: JB
authors.lastname: Gavin
authors.forename: W R
authors.initials: WR
authors.lastname: Wilson
mesh_terms: D000165:Acridine Orange / Q000031:analogs & derivatives; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001808:Blood Vessels / Q000187:drug effects*; D005419:Flavonoids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005453:Fluorescence; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000098:blood supply* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D005419:Flavonoids; C056258:N(10)-nonylacridine orange; C049328:flavone acetic acid; D000165:Acridine Orange